

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 5.13216398 |
| 2 | fatty acid transmembrane transport (GO:1902001) | 4.80352643 |
| 3 | phospholipid homeostasis (GO:0055091) | 4.79538395 |
| 4 | carnitine shuttle (GO:0006853) | 4.78822972 |
| 5 | valine metabolic process (GO:0006573) | 4.24277937 |
| 6 | low-density lipoprotein particle clearance (GO:0034383) | 4.13954519 |
| 7 | regulation of protein activation cascade (GO:2000257) | 4.10289715 |
| 8 | regulation of complement activation (GO:0030449) | 4.08015204 |
| 9 | negative regulation of protein activation cascade (GO:2000258) | 3.96428141 |
| 10 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.82891043 |
| 11 | negative regulation of humoral immune response (GO:0002921) | 3.80614286 |
| 12 | negative regulation of complement activation (GO:0045916) | 3.78510828 |
| 13 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.77671183 |
| 14 | carnitine transmembrane transport (GO:1902603) | 3.75574730 |
| 15 | macroautophagy (GO:0016236) | 3.65419931 |
| 16 | fatty acid beta-oxidation (GO:0006635) | 3.62164855 |
| 17 | regulation of cholesterol storage (GO:0010885) | 3.57698534 |
| 18 | positive regulation of fatty acid oxidation (GO:0046321) | 3.53819205 |
| 19 | biotin metabolic process (GO:0006768) | 3.52012045 |
| 20 | amino-acid betaine transport (GO:0015838) | 3.50832335 |
| 21 | carnitine transport (GO:0015879) | 3.50832335 |
| 22 | histone H3-K36 demethylation (GO:0070544) | 3.47852418 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.47402124 |
| 24 | interkinetic nuclear migration (GO:0022027) | 3.46983708 |
| 25 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.45499334 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.44577607 |
| 27 | urea cycle (GO:0000050) | 3.36810668 |
| 28 | urea metabolic process (GO:0019627) | 3.36810668 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 3.31858105 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 3.31146973 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 3.28343042 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.27343567 |
| 33 | cellular response to ethanol (GO:0071361) | 3.26159383 |
| 34 | fatty acid oxidation (GO:0019395) | 3.24165611 |
| 35 | drug catabolic process (GO:0042737) | 3.22248829 |
| 36 | ethanol oxidation (GO:0006069) | 3.20200664 |
| 37 | regulation of bile acid biosynthetic process (GO:0070857) | 3.18909083 |
| 38 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.17773163 |
| 39 | fatty acid catabolic process (GO:0009062) | 3.15322886 |
| 40 | exogenous drug catabolic process (GO:0042738) | 3.15165394 |
| 41 | lipid oxidation (GO:0034440) | 3.15135518 |
| 42 | positive regulation of cholesterol efflux (GO:0010875) | 3.14627524 |
| 43 | positive regulation of lipid catabolic process (GO:0050996) | 3.14316674 |
| 44 | triglyceride homeostasis (GO:0070328) | 3.12708847 |
| 45 | acylglycerol homeostasis (GO:0055090) | 3.12708847 |
| 46 | homocysteine metabolic process (GO:0050667) | 3.12649139 |
| 47 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.12038731 |
| 48 | intracellular lipid transport (GO:0032365) | 3.11214660 |
| 49 | negative regulation of lipase activity (GO:0060192) | 3.11158562 |
| 50 | negative regulation of B cell mediated immunity (GO:0002713) | 3.09486935 |
| 51 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.09486935 |
| 52 | negative regulation of lipid storage (GO:0010888) | 3.08488177 |
| 53 | 2-oxoglutarate metabolic process (GO:0006103) | 3.06459080 |
| 54 | positive regulation of lipid storage (GO:0010884) | 3.02791996 |
| 55 | positive regulation of cholesterol transport (GO:0032376) | 3.02266139 |
| 56 | positive regulation of sterol transport (GO:0032373) | 3.02266139 |
| 57 | nitrogen cycle metabolic process (GO:0071941) | 2.99394350 |
| 58 | regulation of fatty acid oxidation (GO:0046320) | 2.98933451 |
| 59 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.98407847 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95859479 |
| 61 | skeletal muscle adaptation (GO:0043501) | 2.95811661 |
| 62 | lipoprotein transport (GO:0042953) | 2.95587073 |
| 63 | fatty acid homeostasis (GO:0055089) | 2.90631003 |
| 64 | regulation of humoral immune response (GO:0002920) | 2.89478264 |
| 65 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.89388882 |
| 66 | histone H3-K4 trimethylation (GO:0080182) | 2.88713209 |
| 67 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.88306839 |
| 68 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.87554633 |
| 69 | acetyl-CoA metabolic process (GO:0006084) | 2.86971864 |
| 70 | ethanol metabolic process (GO:0006067) | 2.85736249 |
| 71 | detection of external biotic stimulus (GO:0098581) | 2.83600406 |
| 72 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83310959 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.82222283 |
| 74 | brown fat cell differentiation (GO:0050873) | 2.81374910 |
| 75 | complement activation, alternative pathway (GO:0006957) | 2.80940568 |
| 76 | branched-chain amino acid metabolic process (GO:0009081) | 2.79165585 |
| 77 | cellular extravasation (GO:0045123) | 2.79126704 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79103997 |
| 79 | phospholipid efflux (GO:0033700) | 2.77936602 |
| 80 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77649452 |
| 81 | epoxygenase P450 pathway (GO:0019373) | 2.77052597 |
| 82 | lysine metabolic process (GO:0006553) | 2.76672728 |
| 83 | lysine catabolic process (GO:0006554) | 2.76672728 |
| 84 | negative regulation of fibrinolysis (GO:0051918) | 2.75872540 |
| 85 | monocarboxylic acid catabolic process (GO:0072329) | 2.72710285 |
| 86 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.72475010 |
| 87 | positive regulation of glycolytic process (GO:0045821) | 2.70782323 |
| 88 | positive regulation of p38MAPK cascade (GO:1900745) | 2.70579972 |
| 89 | regulation of lipid storage (GO:0010883) | 2.69854454 |
| 90 | branched-chain amino acid catabolic process (GO:0009083) | 2.67771426 |
| 91 | triglyceride catabolic process (GO:0019433) | 2.67159612 |
| 92 | axonemal dynein complex assembly (GO:0070286) | 2.65657157 |
| 93 | striated muscle atrophy (GO:0014891) | 2.65257241 |
| 94 | amino-acid betaine metabolic process (GO:0006577) | 2.62983113 |
| 95 | I-kappaB phosphorylation (GO:0007252) | 2.62895763 |
| 96 | carnitine metabolic process (GO:0009437) | 2.61727588 |
| 97 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60611514 |
| 98 | L-phenylalanine catabolic process (GO:0006559) | 2.60611514 |
| 99 | regulation of gamma-delta T cell activation (GO:0046643) | 2.60141441 |
| 100 | quaternary ammonium group transport (GO:0015697) | 2.59052428 |
| 101 | regulation of apoptotic cell clearance (GO:2000425) | 2.58608055 |
| 102 | acylglycerol catabolic process (GO:0046464) | 2.58486693 |
| 103 | neutral lipid catabolic process (GO:0046461) | 2.58486693 |
| 104 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.57791834 |
| 105 | lipid homeostasis (GO:0055088) | 2.56878324 |
| 106 | plasma lipoprotein particle assembly (GO:0034377) | 2.56694150 |
| 107 | hormone catabolic process (GO:0042447) | 2.55042772 |
| 108 | iron ion import (GO:0097286) | 2.52715810 |
| 109 | diacylglycerol metabolic process (GO:0046339) | 2.49135740 |
| 110 | regulation of fibrinolysis (GO:0051917) | 2.48973140 |
| 111 | growth hormone receptor signaling pathway (GO:0060396) | 2.48935052 |
| 112 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.48622893 |
| 113 | protein activation cascade (GO:0072376) | 2.47982039 |
| 114 | cardiac muscle hypertrophy (GO:0003300) | 2.47973128 |
| 115 | histone lysine demethylation (GO:0070076) | 2.47689270 |
| 116 | short-chain fatty acid metabolic process (GO:0046459) | 2.45970359 |
| 117 | muscle atrophy (GO:0014889) | 2.44895671 |
| 118 | detection of bacterium (GO:0016045) | 2.44430776 |
| 119 | detection of biotic stimulus (GO:0009595) | 2.44399179 |
| 120 | relaxation of cardiac muscle (GO:0055119) | 2.44082191 |
| 121 | histone H3-K9 demethylation (GO:0033169) | 2.43370622 |
| 122 | Golgi to endosome transport (GO:0006895) | 2.43294987 |
| 123 | aromatic amino acid family catabolic process (GO:0009074) | 2.41890700 |
| 124 | regulation of sterol transport (GO:0032371) | 2.41741044 |
| 125 | regulation of cholesterol transport (GO:0032374) | 2.41741044 |
| 126 | cholesterol efflux (GO:0033344) | 2.41479786 |
| 127 | complement activation, classical pathway (GO:0006958) | 2.41407635 |
| 128 | L-phenylalanine metabolic process (GO:0006558) | 2.41188904 |
| 129 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.41188904 |
| 130 | detection of other organism (GO:0098543) | 2.40314112 |
| 131 | nucleus localization (GO:0051647) | 2.40050643 |
| 132 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.39045626 |
| 133 | cholesterol homeostasis (GO:0042632) | 2.38307616 |
| 134 | complement activation (GO:0006956) | 2.37533856 |
| 135 | acute-phase response (GO:0006953) | 2.36348139 |
| 136 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.36342322 |
| 137 | lipid storage (GO:0019915) | 2.34742395 |
| 138 | sterol homeostasis (GO:0055092) | 2.34257338 |
| 139 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.33177480 |
| 140 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.32295767 |
| 141 | lipoprotein metabolic process (GO:0042157) | 2.31789729 |
| 142 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.31476793 |
| 143 | negative regulation of granulocyte differentiation (GO:0030853) | 2.31326840 |
| 144 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.31042253 |
| 145 | histone demethylation (GO:0016577) | 2.30139929 |
| 146 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.29858928 |
| 147 | high-density lipoprotein particle remodeling (GO:0034375) | 2.27065149 |
| 148 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.26609179 |
| 149 | hypotonic response (GO:0006971) | 2.26059773 |
| 150 | macrophage activation (GO:0042116) | 2.24945104 |
| 151 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.24200817 |
| 152 | epithelial structure maintenance (GO:0010669) | 2.24197735 |
| 153 | negative regulation of cholesterol transport (GO:0032375) | 2.23877884 |
| 154 | negative regulation of sterol transport (GO:0032372) | 2.23877884 |
| 155 | blood coagulation, intrinsic pathway (GO:0007597) | 2.21701048 |
| 156 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.21615975 |
| 157 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.21615975 |
| 158 | modulation by symbiont of host immune response (GO:0052553) | 2.21615975 |
| 159 | positive regulation by symbiont of host defense response (GO:0052509) | 2.21615975 |
| 160 | modulation by symbiont of host defense response (GO:0052031) | 2.21615975 |
| 161 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.21615975 |
| 162 | cilium movement (GO:0003341) | 2.21603654 |
| 163 | macrophage activation involved in immune response (GO:0002281) | 2.20798553 |
| 164 | lipid translocation (GO:0034204) | 2.20220059 |
| 165 | phospholipid translocation (GO:0045332) | 2.20220059 |
| 166 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.20199673 |
| 167 | negative regulation of myotube differentiation (GO:0010832) | 2.19605688 |
| 168 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.19024611 |
| 169 | plasma lipoprotein particle remodeling (GO:0034369) | 2.18868643 |
| 170 | protein-lipid complex remodeling (GO:0034368) | 2.18868643 |
| 171 | macromolecular complex remodeling (GO:0034367) | 2.18868643 |
| 172 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.18154032 |
| 173 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.17948974 |
| 174 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.17948974 |
| 175 | definitive hemopoiesis (GO:0060216) | 2.15571741 |
| 176 | plasma lipoprotein particle organization (GO:0071827) | 2.14033908 |
| 177 | flavonoid metabolic process (GO:0009812) | 2.12995062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81865198 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.45378656 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09371794 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.03173901 |
| 5 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.81350358 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.63199788 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.62670833 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.49053773 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.45069632 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30793773 |
| 11 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.25074853 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.21300587 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.98083430 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91769335 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83783405 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.78986406 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77854958 |
| 18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.75930278 |
| 19 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.67131092 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66292409 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66217799 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62248861 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61070227 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60529673 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.57550829 |
| 26 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52735947 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52342500 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50757347 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50102264 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49440253 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48899909 |
| 32 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.48296949 |
| 33 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.48014906 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48010914 |
| 35 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46894043 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41959202 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32861906 |
| 38 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32736431 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32710207 |
| 40 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31552844 |
| 41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.30402054 |
| 42 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.30337702 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28772241 |
| 44 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26622242 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25899508 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25245718 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24631026 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23645273 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22763621 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21350928 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19228082 |
| 52 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17991228 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16046331 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14903523 |
| 55 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14408836 |
| 56 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14228020 |
| 57 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14228020 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13752423 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13645529 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.12732226 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12562501 |
| 62 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11697154 |
| 63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11480057 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10866541 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10558534 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09114608 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07954177 |
| 68 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06381409 |
| 69 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06338491 |
| 70 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06261896 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04012039 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03622854 |
| 73 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02821904 |
| 74 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.01520485 |
| 75 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01124264 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99748526 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98907543 |
| 78 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98881228 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98779760 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98779760 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98022077 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97460728 |
| 83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97174424 |
| 84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97083347 |
| 85 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.96737044 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94606213 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94226507 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.94078784 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94032453 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93053739 |
| 91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92935974 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92912400 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92628432 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91688469 |
| 95 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90764954 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90034505 |
| 97 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89723619 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89193961 |
| 99 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89000081 |
| 100 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89000081 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88898038 |
| 102 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87944848 |
| 103 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87877520 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87455445 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86202662 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86185803 |
| 107 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86133058 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86126316 |
| 109 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86062106 |
| 110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85955506 |
| 111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85876148 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84422905 |
| 113 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.84410471 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.83905325 |
| 115 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.83686246 |
| 116 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.83633628 |
| 117 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83208993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.29780016 |
| 2 | MP0005670_abnormal_white_adipose | 4.25514070 |
| 3 | MP0005365_abnormal_bile_salt | 4.01472873 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.99784632 |
| 5 | MP0005360_urolithiasis | 3.94789242 |
| 6 | MP0004130_abnormal_muscle_cell | 3.25193532 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.18613967 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.04819021 |
| 9 | MP0005666_abnormal_adipose_tissue | 2.75743335 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.69634524 |
| 11 | MP0002009_preneoplasia | 2.47715456 |
| 12 | MP0003252_abnormal_bile_duct | 2.45141657 |
| 13 | MP0002254_reproductive_system_inflammat | 2.39374553 |
| 14 | MP0003303_peritoneal_inflammation | 2.32159211 |
| 15 | MP0005409_darkened_coat_color | 2.29626061 |
| 16 | MP0004510_myositis | 2.15842409 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.13327458 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 2.03851816 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.03364186 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.01025745 |
| 21 | MP0005083_abnormal_biliary_tract | 1.93687447 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 1.87641553 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.86815388 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.83284009 |
| 25 | MP0003646_muscle_fatigue | 1.80129366 |
| 26 | MP0005375_adipose_tissue_phenotype | 1.79084172 |
| 27 | MP0000383_abnormal_hair_follicle | 1.75657421 |
| 28 | MP0002971_abnormal_brown_adipose | 1.75566089 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.74615269 |
| 30 | MP0004043_abnormal_pH_regulation | 1.74041874 |
| 31 | MP0003045_fibrosis | 1.73089512 |
| 32 | MP0000609_abnormal_liver_physiology | 1.71037796 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.69162390 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.68480657 |
| 35 | MP0008004_abnormal_stomach_pH | 1.67528724 |
| 36 | MP0005334_abnormal_fat_pad | 1.65191487 |
| 37 | MP0005451_abnormal_body_composition | 1.62751631 |
| 38 | MP0003868_abnormal_feces_composition | 1.61921571 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.61756487 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.60859396 |
| 41 | MP0010678_abnormal_skin_adnexa | 1.60473760 |
| 42 | MP0000751_myopathy | 1.57870104 |
| 43 | MP0005310_abnormal_salivary_gland | 1.50270430 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.50050286 |
| 45 | MP0002132_abnormal_respiratory_system | 1.49809048 |
| 46 | MP0005647_abnormal_sex_gland | 1.47405486 |
| 47 | MP0009115_abnormal_fat_cell | 1.45261077 |
| 48 | MP0004883_abnormal_blood_vessel | 1.44213736 |
| 49 | MP0008775_abnormal_heart_ventricle | 1.41352822 |
| 50 | MP0001873_stomach_inflammation | 1.39872192 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.38221556 |
| 52 | MP0003866_abnormal_defecation | 1.36599230 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.35751293 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.34494091 |
| 55 | MP0003436_decreased_susceptibility_to | 1.32546560 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.31792429 |
| 57 | MP0000566_synostosis | 1.29830041 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.29827336 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.29147475 |
| 60 | MP0000371_diluted_coat_color | 1.28596771 |
| 61 | MP0005164_abnormal_response_to | 1.28312363 |
| 62 | MP0005448_abnormal_energy_balance | 1.28061509 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.21412913 |
| 64 | MP0001661_extended_life_span | 1.21407674 |
| 65 | MP0001851_eye_inflammation | 1.21259325 |
| 66 | MP0003828_pulmonary_edema | 1.21252633 |
| 67 | MP0002909_abnormal_adrenal_gland | 1.18022854 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 1.15945413 |
| 69 | MP0005332_abnormal_amino_acid | 1.15277845 |
| 70 | MP0005330_cardiomyopathy | 1.14391835 |
| 71 | MP0005174_abnormal_tail_pigmentation | 1.13771865 |
| 72 | MP0002419_abnormal_innate_immunity | 1.13679336 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.13614723 |
| 74 | MP0010630_abnormal_cardiac_muscle | 1.10959421 |
| 75 | MP0005535_abnormal_body_temperature | 1.09227839 |
| 76 | MP0002972_abnormal_cardiac_muscle | 1.08709617 |
| 77 | MP0000003_abnormal_adipose_tissue | 1.07703884 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 1.06478885 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 1.06413584 |
| 80 | MP0009840_abnormal_foam_cell | 1.05591545 |
| 81 | MP0003943_abnormal_hepatobiliary_system | 1.05421390 |
| 82 | MP0010368_abnormal_lymphatic_system | 1.05357079 |
| 83 | MP0003690_abnormal_glial_cell | 1.04993172 |
| 84 | MP0000685_abnormal_immune_system | 1.04114656 |
| 85 | MP0005385_cardiovascular_system_phenoty | 1.03614856 |
| 86 | MP0001544_abnormal_cardiovascular_syste | 1.03614856 |
| 87 | MP0005025_abnormal_response_to | 1.02467934 |
| 88 | MP0009763_increased_sensitivity_to | 0.99574066 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.98591485 |
| 90 | MP0004087_abnormal_muscle_fiber | 0.97704372 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.97057196 |
| 92 | MP0003724_increased_susceptibility_to | 0.94951764 |
| 93 | MP0002006_tumorigenesis | 0.92535014 |
| 94 | MP0002970_abnormal_white_adipose | 0.92407625 |
| 95 | MP0001764_abnormal_homeostasis | 0.91942638 |
| 96 | MP0004036_abnormal_muscle_relaxation | 0.90582737 |
| 97 | MP0000249_abnormal_blood_vessel | 0.89457595 |
| 98 | MP0009764_decreased_sensitivity_to | 0.89237979 |
| 99 | MP0000427_abnormal_hair_cycle | 0.88021136 |
| 100 | MP0009697_abnormal_copulation | 0.87750512 |
| 101 | MP0002928_abnormal_bile_duct | 0.87446585 |
| 102 | MP0003763_abnormal_thymus_physiology | 0.87001800 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.86840211 |
| 104 | MP0002396_abnormal_hematopoietic_system | 0.86677722 |
| 105 | MP0001800_abnormal_humoral_immune | 0.86066252 |
| 106 | MP0002106_abnormal_muscle_physiology | 0.85894737 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.84055004 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.83900366 |
| 109 | MP0002127_abnormal_cardiovascular_syste | 0.83551795 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.83389035 |
| 111 | MP0005620_abnormal_muscle_contractility | 0.82848942 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82597390 |
| 113 | MP0000749_muscle_degeneration | 0.82052618 |
| 114 | MP0008260_abnormal_autophagy | 0.81629219 |
| 115 | MP0004484_altered_response_of | 0.81424215 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.80762304 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.78649344 |
| 118 | MP0001915_intracranial_hemorrhage | 0.78610366 |
| 119 | MP0002168_other_aberrant_phenotype | 0.78222499 |
| 120 | MP0001835_abnormal_antigen_presentation | 0.76903907 |
| 121 | MP0002405_respiratory_system_inflammati | 0.76556598 |
| 122 | MP0003195_calcinosis | 0.76108930 |
| 123 | MP0010234_abnormal_vibrissa_follicle | 0.75068107 |
| 124 | MP0000015_abnormal_ear_pigmentation | 0.73804028 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.73397965 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.72788825 |
| 127 | MP0004381_abnormal_hair_follicle | 0.72552622 |
| 128 | MP0003890_abnormal_embryonic-extraembry | 0.71967305 |
| 129 | MP0009643_abnormal_urine_homeostasis | 0.70973295 |
| 130 | MP0000604_amyloidosis | 0.70605843 |
| 131 | MP0004147_increased_porphyrin_level | 0.69759774 |
| 132 | MP0005369_muscle_phenotype | 0.69462738 |
| 133 | MP0008469_abnormal_protein_level | 0.69099737 |
| 134 | MP0001790_abnormal_immune_system | 0.67190809 |
| 135 | MP0005387_immune_system_phenotype | 0.67190809 |
| 136 | MP0002108_abnormal_muscle_morphology | 0.67095435 |
| 137 | MP0003705_abnormal_hypodermis_morpholog | 0.65780363 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65533214 |
| 139 | MP0006138_congestive_heart_failure | 0.65522907 |
| 140 | MP0001845_abnormal_inflammatory_respons | 0.65470603 |
| 141 | MP0005645_abnormal_hypothalamus_physiol | 0.65402867 |
| 142 | MP0005167_abnormal_blood-brain_barrier | 0.64764362 |
| 143 | MP0005397_hematopoietic_system_phenotyp | 0.64459298 |
| 144 | MP0003959_abnormal_lean_body | 0.64113125 |
| 145 | MP0009278_abnormal_bone_marrow | 0.63711304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epidermoid cyst (HP:0200040) | 3.69714403 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 3.61436571 |
| 3 | Hypoglycemic coma (HP:0001325) | 3.57892494 |
| 4 | Papillary thyroid carcinoma (HP:0002895) | 3.33042590 |
| 5 | Hypoalphalipoproteinemia (HP:0003233) | 3.32911465 |
| 6 | Hyperkalemia (HP:0002153) | 3.28659323 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.19019711 |
| 8 | Ketosis (HP:0001946) | 3.16824707 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.14177531 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.11264973 |
| 11 | Absent/shortened dynein arms (HP:0200106) | 3.10801006 |
| 12 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.10801006 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 3.08034673 |
| 14 | Hydroxyprolinuria (HP:0003080) | 3.08034673 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.07801324 |
| 16 | Hyperglycinuria (HP:0003108) | 3.01696297 |
| 17 | Flat acetabular roof (HP:0003180) | 3.01375582 |
| 18 | Glomerulonephritis (HP:0000099) | 2.97562073 |
| 19 | Abnormality of complement system (HP:0005339) | 2.97319305 |
| 20 | Xanthomatosis (HP:0000991) | 2.97238705 |
| 21 | Sudden death (HP:0001699) | 2.95703446 |
| 22 | Abnormal ciliary motility (HP:0012262) | 2.87203027 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 2.87168519 |
| 24 | Abnormality of the fingertips (HP:0001211) | 2.86288872 |
| 25 | Ketoacidosis (HP:0001993) | 2.85127939 |
| 26 | Ventricular tachycardia (HP:0004756) | 2.82899695 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 2.82784748 |
| 28 | Syncope (HP:0001279) | 2.82660562 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.81691634 |
| 30 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.79151034 |
| 31 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.78725070 |
| 32 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.78725070 |
| 33 | Atrial fibrillation (HP:0005110) | 2.77520744 |
| 34 | Muscle fiber inclusion bodies (HP:0100299) | 2.76759756 |
| 35 | Complement deficiency (HP:0004431) | 2.76488113 |
| 36 | Hypercholesterolemia (HP:0003124) | 2.73258289 |
| 37 | Myoglobinuria (HP:0002913) | 2.67528210 |
| 38 | Hyperactive renin-angiotensin system (HP:0000841) | 2.65991952 |
| 39 | Skin nodule (HP:0200036) | 2.65709670 |
| 40 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.65623883 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.64436364 |
| 42 | Nemaline bodies (HP:0003798) | 2.61890737 |
| 43 | Hyperammonemia (HP:0001987) | 2.61874103 |
| 44 | Deep venous thrombosis (HP:0002625) | 2.61680716 |
| 45 | Rhinitis (HP:0012384) | 2.60637275 |
| 46 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.57984061 |
| 47 | Gingival bleeding (HP:0000225) | 2.57476198 |
| 48 | Joint hemorrhage (HP:0005261) | 2.56693689 |
| 49 | Hyperglycemia (HP:0003074) | 2.55741983 |
| 50 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.54864029 |
| 51 | Renal cortical cysts (HP:0000803) | 2.54078714 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.53427744 |
| 53 | Hypoglycemic seizures (HP:0002173) | 2.51973797 |
| 54 | Abnormality of the nasal septum (HP:0000419) | 2.50788367 |
| 55 | Hematochezia (HP:0002573) | 2.50617524 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.50043315 |
| 57 | Hypolipoproteinemia (HP:0010981) | 2.49268826 |
| 58 | Myocardial infarction (HP:0001658) | 2.47969724 |
| 59 | Primary atrial arrhythmia (HP:0001692) | 2.47813006 |
| 60 | Pigmentary retinal degeneration (HP:0001146) | 2.46791312 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.44693891 |
| 62 | Bronchiectasis (HP:0002110) | 2.44406912 |
| 63 | Prostate neoplasm (HP:0100787) | 2.44242627 |
| 64 | Hypertriglyceridemia (HP:0002155) | 2.42184020 |
| 65 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.39310265 |
| 66 | Hypobetalipoproteinemia (HP:0003563) | 2.37331018 |
| 67 | Calf muscle hypertrophy (HP:0008981) | 2.37054453 |
| 68 | Myositis (HP:0100614) | 2.34324546 |
| 69 | Oligomenorrhea (HP:0000876) | 2.33920197 |
| 70 | Abnormality of glycine metabolism (HP:0010895) | 2.31573929 |
| 71 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.31573929 |
| 72 | Orchitis (HP:0100796) | 2.29627412 |
| 73 | Decreased circulating renin level (HP:0003351) | 2.29443779 |
| 74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.28743670 |
| 75 | Lipoatrophy (HP:0100578) | 2.27703602 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.24879328 |
| 77 | Optic neuritis (HP:0100653) | 2.24879328 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.24715650 |
| 79 | Muscle fiber splitting (HP:0003555) | 2.24514184 |
| 80 | Supraventricular tachycardia (HP:0004755) | 2.23962201 |
| 81 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.22767264 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.22283921 |
| 83 | Supraventricular arrhythmia (HP:0005115) | 2.20489937 |
| 84 | Abnormality of vision evoked potentials (HP:0000649) | 2.17788492 |
| 85 | Dicarboxylic aciduria (HP:0003215) | 2.17303893 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17303893 |
| 87 | Nephritis (HP:0000123) | 2.15578819 |
| 88 | Esophageal varix (HP:0002040) | 2.15049236 |
| 89 | Chronic bronchitis (HP:0004469) | 2.14942075 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.14766108 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14472835 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.13546366 |
| 93 | Dilated cardiomyopathy (HP:0001644) | 2.13408279 |
| 94 | Recurrent bacterial skin infections (HP:0005406) | 2.12586571 |
| 95 | Prolonged QT interval (HP:0001657) | 2.12528641 |
| 96 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.10912598 |
| 97 | Recurrent abscess formation (HP:0002722) | 2.09078066 |
| 98 | Toxemia of pregnancy (HP:0100603) | 2.07986193 |
| 99 | Abnormality of purine metabolism (HP:0004352) | 2.06715180 |
| 100 | Long toe (HP:0010511) | 2.04974363 |
| 101 | Difficulty running (HP:0009046) | 2.02144078 |
| 102 | Tetraparesis (HP:0002273) | 2.01358299 |
| 103 | Macroorchidism (HP:0000053) | 2.00814459 |
| 104 | Thick nail (HP:0001805) | 2.00708120 |
| 105 | Periodontitis (HP:0000704) | 2.00431095 |
| 106 | Gingivitis (HP:0000230) | 1.99252167 |
| 107 | Abnormality of chloride homeostasis (HP:0011422) | 1.97257656 |
| 108 | Subaortic stenosis (HP:0001682) | 1.95951076 |
| 109 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.95951076 |
| 110 | Palpitations (HP:0001962) | 1.95465898 |
| 111 | Prolonged bleeding time (HP:0003010) | 1.95029459 |
| 112 | Hemorrhage of the eye (HP:0011885) | 1.93837738 |
| 113 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91542185 |
| 114 | Pulmonary embolism (HP:0002204) | 1.90738990 |
| 115 | Increased connective tissue (HP:0009025) | 1.89773126 |
| 116 | Nausea (HP:0002018) | 1.88533875 |
| 117 | Spontaneous abortion (HP:0005268) | 1.88095775 |
| 118 | Central scotoma (HP:0000603) | 1.87765317 |
| 119 | Frequent falls (HP:0002359) | 1.87497968 |
| 120 | Recurrent sinusitis (HP:0011108) | 1.87300605 |
| 121 | Amyloidosis (HP:0011034) | 1.87284314 |
| 122 | Cholelithiasis (HP:0001081) | 1.86548836 |
| 123 | Hypoplastic ischia (HP:0003175) | 1.85061289 |
| 124 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.84547401 |
| 125 | Recurrent cutaneous fungal infections (HP:0011370) | 1.84547401 |
| 126 | Abnormality of the renal cortex (HP:0011035) | 1.84269196 |
| 127 | Turricephaly (HP:0000262) | 1.83762958 |
| 128 | Abnormality of nucleobase metabolism (HP:0010932) | 1.83366226 |
| 129 | Portal hypertension (HP:0001409) | 1.82974912 |
| 130 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82586045 |
| 131 | Hypochromic microcytic anemia (HP:0004840) | 1.82491574 |
| 132 | Rhabdomyolysis (HP:0003201) | 1.82311056 |
| 133 | Colitis (HP:0002583) | 1.81904335 |
| 134 | Symptomatic seizures (HP:0011145) | 1.81556366 |
| 135 | Long foot (HP:0001833) | 1.81232399 |
| 136 | Autoimmune thrombocytopenia (HP:0001973) | 1.81058652 |
| 137 | Osteomalacia (HP:0002749) | 1.80929567 |
| 138 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.80896815 |
| 139 | Thyroid carcinoma (HP:0002890) | 1.80175384 |
| 140 | Heterotopia (HP:0002282) | 1.79477672 |
| 141 | Keratoconjunctivitis sicca (HP:0001097) | 1.79087031 |
| 142 | Visceral angiomatosis (HP:0100761) | 1.78849872 |
| 143 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.78638604 |
| 144 | Germ cell neoplasia (HP:0100728) | 1.77798517 |
| 145 | Abnormality of methionine metabolism (HP:0010901) | 1.77560888 |
| 146 | Neonatal hypoglycemia (HP:0001998) | 1.76846512 |
| 147 | Ventricular arrhythmia (HP:0004308) | 1.76517426 |
| 148 | Abnormality of the intrinsic pathway (HP:0010989) | 1.75848870 |
| 149 | Pancreatitis (HP:0001733) | 1.75834977 |
| 150 | Hypoplasia of the thymus (HP:0000778) | 1.75121086 |
| 151 | Malnutrition (HP:0004395) | 1.75113963 |
| 152 | Metabolic acidosis (HP:0001942) | 1.75041157 |
| 153 | Truncal obesity (HP:0001956) | 1.74612979 |
| 154 | Urethral obstruction (HP:0000796) | 1.73611175 |
| 155 | Subacute progressive viral hepatitis (HP:0006572) | 1.73420949 |
| 156 | Fat malabsorption (HP:0002630) | 1.73406506 |
| 157 | Thrombophlebitis (HP:0004418) | 1.73372973 |
| 158 | Bundle branch block (HP:0011710) | 1.73300843 |
| 159 | Epistaxis (HP:0000421) | 1.72778733 |
| 160 | Hepatoblastoma (HP:0002884) | 1.72326904 |
| 161 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.71987855 |
| 162 | Fair hair (HP:0002286) | 1.71262732 |
| 163 | Abnormality of potassium homeostasis (HP:0011042) | 1.70007313 |
| 164 | Genetic anticipation (HP:0003743) | 1.69490439 |
| 165 | Abnormality of secondary sexual hair (HP:0009888) | 1.67267252 |
| 166 | Abnormality of the axillary hair (HP:0100134) | 1.67267252 |
| 167 | Tubulointerstitial nephritis (HP:0001970) | 1.66928587 |
| 168 | Recurrent skin infections (HP:0001581) | 1.66619030 |
| 169 | Arterial thrombosis (HP:0004420) | 1.66147246 |
| 170 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.65933031 |
| 171 | Laryngomalacia (HP:0001601) | 1.63243421 |
| 172 | Hemangiomatosis (HP:0007461) | 1.62020445 |
| 173 | Bifid scrotum (HP:0000048) | 1.62004425 |
| 174 | Dysmetric saccades (HP:0000641) | 1.61219368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 4.01139749 |
| 2 | INSRR | 3.51806362 |
| 3 | CAMK1G | 3.22828299 |
| 4 | IRAK3 | 2.98017401 |
| 5 | MAP3K14 | 2.47993484 |
| 6 | SIK1 | 2.35520893 |
| 7 | TAOK3 | 2.33734590 |
| 8 | LMTK2 | 2.02205071 |
| 9 | TTN | 1.98545682 |
| 10 | NLK | 1.97291910 |
| 11 | JAK1 | 1.91702542 |
| 12 | LATS1 | 1.86140481 |
| 13 | FRK | 1.79370438 |
| 14 | DAPK2 | 1.75521962 |
| 15 | TYK2 | 1.75479436 |
| 16 | BCKDK | 1.74908594 |
| 17 | MAP3K13 | 1.73773098 |
| 18 | CDK12 | 1.73297239 |
| 19 | MAP3K2 | 1.69160562 |
| 20 | PRKAA2 | 1.68066963 |
| 21 | IKBKE | 1.65755999 |
| 22 | MAP2K3 | 1.63214162 |
| 23 | PIK3CG | 1.62318608 |
| 24 | BLK | 1.57963643 |
| 25 | TNK2 | 1.51568799 |
| 26 | FGFR4 | 1.51360935 |
| 27 | TAOK1 | 1.49048158 |
| 28 | EEF2K | 1.41253956 |
| 29 | MAP3K7 | 1.39999856 |
| 30 | SGK2 | 1.38302423 |
| 31 | PTK6 | 1.35886863 |
| 32 | BRD4 | 1.34990446 |
| 33 | PKN2 | 1.32556431 |
| 34 | SGK3 | 1.31750287 |
| 35 | FGFR3 | 1.26021384 |
| 36 | RIPK1 | 1.23106553 |
| 37 | SIK2 | 1.21352001 |
| 38 | JAK3 | 1.17017729 |
| 39 | PRKAA1 | 1.14625954 |
| 40 | FLT3 | 1.09932488 |
| 41 | MAPK15 | 1.09756787 |
| 42 | FES | 1.09746803 |
| 43 | ERN1 | 1.09558282 |
| 44 | ZAK | 1.08939859 |
| 45 | TRPM7 | 1.07136287 |
| 46 | TEC | 1.06093802 |
| 47 | TIE1 | 1.06016367 |
| 48 | ACVR1B | 1.04217507 |
| 49 | OBSCN | 1.02536160 |
| 50 | NUAK1 | 1.01264016 |
| 51 | MAP2K4 | 1.01214140 |
| 52 | CHUK | 1.00425532 |
| 53 | PHKG2 | 0.99015153 |
| 54 | PHKG1 | 0.99015153 |
| 55 | PIK3CA | 0.97600462 |
| 56 | IRAK4 | 0.95670570 |
| 57 | TBK1 | 0.94374201 |
| 58 | STK39 | 0.94313687 |
| 59 | PDK4 | 0.93253131 |
| 60 | PDK3 | 0.93253131 |
| 61 | MST1R | 0.90254263 |
| 62 | ZAP70 | 0.88868854 |
| 63 | PRPF4B | 0.86486874 |
| 64 | JAK2 | 0.85324427 |
| 65 | CDK9 | 0.84653402 |
| 66 | KIT | 0.84035935 |
| 67 | MAP3K3 | 0.82657413 |
| 68 | SGK1 | 0.81706325 |
| 69 | CDK6 | 0.81089694 |
| 70 | STK11 | 0.80886889 |
| 71 | MTOR | 0.80806911 |
| 72 | BTK | 0.80479370 |
| 73 | PKN1 | 0.77412780 |
| 74 | TGFBR2 | 0.73173220 |
| 75 | NEK9 | 0.72780016 |
| 76 | EIF2AK2 | 0.72555421 |
| 77 | PDGFRB | 0.71239885 |
| 78 | DMPK | 0.70610762 |
| 79 | FGR | 0.70560552 |
| 80 | FER | 0.70537550 |
| 81 | SGK223 | 0.69802803 |
| 82 | SGK494 | 0.69802803 |
| 83 | IRAK2 | 0.69761837 |
| 84 | MAP2K6 | 0.67960255 |
| 85 | PRKD2 | 0.66515050 |
| 86 | MAP3K1 | 0.66367009 |
| 87 | MELK | 0.65052504 |
| 88 | NTRK3 | 0.64894103 |
| 89 | STK24 | 0.64549447 |
| 90 | TRIB3 | 0.64299798 |
| 91 | HIPK2 | 0.63612282 |
| 92 | MARK2 | 0.63542704 |
| 93 | FGFR2 | 0.62920227 |
| 94 | IKBKB | 0.62630928 |
| 95 | CAMK4 | 0.61738678 |
| 96 | ERBB2 | 0.61571206 |
| 97 | MAPK11 | 0.60275366 |
| 98 | MAP3K6 | 0.60215624 |
| 99 | STK38 | 0.59754482 |
| 100 | EPHA3 | 0.59156754 |
| 101 | MAP4K1 | 0.58672543 |
| 102 | CDC42BPA | 0.58347781 |
| 103 | ITK | 0.58066863 |
| 104 | MAPK12 | 0.57821008 |
| 105 | HCK | 0.57689472 |
| 106 | MAPK7 | 0.57563419 |
| 107 | PINK1 | 0.55600477 |
| 108 | TXK | 0.55412432 |
| 109 | ICK | 0.54413318 |
| 110 | OXSR1 | 0.53996792 |
| 111 | IRAK1 | 0.52533255 |
| 112 | MAP3K4 | 0.50908366 |
| 113 | EPHB1 | 0.50457429 |
| 114 | YES1 | 0.50090005 |
| 115 | WNK1 | 0.49294207 |
| 116 | CSK | 0.49230835 |
| 117 | GRK6 | 0.48275452 |
| 118 | LCK | 0.48225678 |
| 119 | LYN | 0.47576082 |
| 120 | SYK | 0.47573713 |
| 121 | RIPK4 | 0.47451098 |
| 122 | AKT3 | 0.46385880 |
| 123 | STK3 | 0.44911939 |
| 124 | RET | 0.43926263 |
| 125 | CAMK2D | 0.42853752 |
| 126 | PDGFRA | 0.41728551 |
| 127 | PRKACG | 0.41202031 |
| 128 | PTK2 | 0.41127636 |
| 129 | CSF1R | 0.40824679 |
| 130 | CAMK1 | 0.40554631 |
| 131 | PTK2B | 0.40195655 |
| 132 | PDK1 | 0.38473793 |
| 133 | GSK3A | 0.37839144 |
| 134 | PRKD1 | 0.36678243 |
| 135 | EGFR | 0.36455269 |
| 136 | PDPK1 | 0.34989179 |
| 137 | PRKCH | 0.34978448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.92606423 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.88665238 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.66943355 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63268292 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.42905142 |
| 6 | Lysine degradation_Homo sapiens_hsa00310 | 2.19068343 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17661773 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.15286634 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14627405 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.11520893 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.05347383 |
| 12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.04430223 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 2.02683128 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72786573 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.63777387 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60035990 |
| 17 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.59087735 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58613955 |
| 19 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.53116057 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52160326 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51078033 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47720153 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.47268136 |
| 24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.45857779 |
| 25 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.43549642 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41836070 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.40942181 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.38150303 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.35592844 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.27218483 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23840098 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.19828495 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17395704 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15715084 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.14889424 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.13540137 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10597482 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06823630 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04556457 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99885501 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 0.99688158 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99663223 |
| 43 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97904940 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95075130 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94216545 |
| 46 | Prostate cancer_Homo sapiens_hsa05215 | 0.93420875 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93024509 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92655487 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91457571 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91104213 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88468762 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88386417 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87159912 |
| 54 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85393331 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83358588 |
| 56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83064411 |
| 57 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82198686 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81247438 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80796803 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80193388 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79720157 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79075788 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76062988 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75616486 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75548995 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73224980 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72724200 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72552866 |
| 69 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71721077 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71050100 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.70865014 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69944726 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69762575 |
| 74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69332657 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69226951 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68360944 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67931081 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67835466 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.67194620 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66986593 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65806191 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65589595 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64746119 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63804523 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62759343 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59539386 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.58982124 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58942341 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58363756 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57591678 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.56888498 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56610327 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56362416 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53598918 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52832641 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52584944 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52067942 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.52038530 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51349287 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50901541 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50775420 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50730949 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49511375 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49500530 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49451645 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49253497 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48781455 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.48186704 |
| 109 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47181655 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47164065 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47023186 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.46453746 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46162519 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45892853 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45551418 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45428899 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.42657613 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42452730 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41830904 |
| 120 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40467708 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39062920 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37137966 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35040585 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33255834 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30997777 |
| 126 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30406651 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28656481 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.28576481 |
| 129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.28081092 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27161318 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26763023 |
| 132 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.26591963 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25753652 |
| 134 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23973413 |
| 135 | Tuberculosis_Homo sapiens_hsa05152 | 0.23197301 |
| 136 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22184206 |
| 137 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21678598 |

